Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study.

Francesco Liistro,Paolo Angioli,Italo Porto,Kenneth Ducci,Giovanni Falsini,Giorgio Ventoruzzo,Lucia Ricci,Alessia Scatena,Simone Grotti,Leonardo Bolognese

Journal of the American College of Cardiology（2019）

引用 41|浏览32

暂无评分

摘要

DCB was not superior to DES in the treatment of complex FP lesions in a high-risk population, yielding similar rate of restenosis and clinically driven target lesion revascularization. (Paclitaxel-Eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-Eluting Stent for the Treatment of Femoropopliteal De Novo Lesions; NCT01969630).

查看译文

关键词

DCB,DES,restenosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要